AAAAAA

   
Results: 1-3 |
Results: 3
A RANDOMIZED CLINICAL-TRIAL OF PRIMARY CHEMOTHERAPY (PC) WITH TAXOL PLUS EPIRUBICIN (TE) - V - 5-FU PLUS EPIRUBICIN PLUS CYCLOPHOSPHAMIDE (FEC) IN STAGE IIIA BREAST-CANCER - A PRELIMINARY-REPORT
Authors: MALAMOS N PAPADIAMANTIS I ANDONOPOULOS M TSIKKINIS A KOSMAS H PALLIS L KOURI E SFIKAS K
Citation: N. Malamos et al., A RANDOMIZED CLINICAL-TRIAL OF PRIMARY CHEMOTHERAPY (PC) WITH TAXOL PLUS EPIRUBICIN (TE) - V - 5-FU PLUS EPIRUBICIN PLUS CYCLOPHOSPHAMIDE (FEC) IN STAGE IIIA BREAST-CANCER - A PRELIMINARY-REPORT, European journal of cancer, 34, 1998, pp. 50-50
PROSPECTIVE RANDOMIZED STUDY OF NEOADJUVANT CHEMOTHERAPY (NACT) WITH PACLITAXEL EPIRUBICIN (PE) VERSUS FLUOROURACIL/EPIRUBICIN/CYCLOPHOSPHAMIDE (FEC) IN OPERABLE STAGE II-IIIA BREAST-CANCER (BC)/
Authors: MALAMOS N KOSMAS C ANTONOPOULOS MJ TSIKKINIS A PALLIS L PAPADIAMANTIS J KOURI E VASILAROS S
Citation: N. Malamos et al., PROSPECTIVE RANDOMIZED STUDY OF NEOADJUVANT CHEMOTHERAPY (NACT) WITH PACLITAXEL EPIRUBICIN (PE) VERSUS FLUOROURACIL/EPIRUBICIN/CYCLOPHOSPHAMIDE (FEC) IN OPERABLE STAGE II-IIIA BREAST-CANCER (BC)/, Annals of oncology, 9, 1998, pp. 105-105
MICROSATELLITE INSTABILITY AND LOSS OF HETEROZYGOSITY IN PRIMARY BREAST-TUMORS
Authors: SOURVINOS G KIARIS H TSIKKINIS A VASSILAROS S SPANDIDOS DA
Citation: G. Sourvinos et al., MICROSATELLITE INSTABILITY AND LOSS OF HETEROZYGOSITY IN PRIMARY BREAST-TUMORS, Tumor biology, 18(3), 1997, pp. 157-166
Risultati: 1-3 |